NIH-funded study in mice suggests lymphatic boost could help reduce amyloid buildup.
Study of mouse brain shows the meningeal lymphatics system (purple and pink) could help reduce amyloid. Sandro Da Mesquita, Ph.D.
Enhancing the brainâs lymphatic system when administering immunotherapies may lead to better clinical outcomes for Alzheimerâs disease patients, according to a new study in mice. Results published April 28 in
Nature suggest that treatments such as the immunotherapies BAN2401 or aducanumab might be more effective when the brainâs lymphatic system can better drain the amyloid-beta protein that accumulates in the brains of those living with Alzheimerâs. Major funding for the research was provided by the National Institute on Aging (NIA), part of the National Institutes of Health, and all study data is now freely available to the broader scientific community.
HIN
Enhancing the brain’s lymphatic system when administering immunotherapies may lead to better clinical outcomes for Alzheimer’s disease patients, according to a new study in mice. Results published April 28 in Nature suggest that treatments such as the immunotherapies BAN2401 or aducanumab might be more effective when the brain’s lymphatic system can better drain the amyloid-beta protein that accumulates in the brains of those living with Alzheimer’s. Major funding for the research was provided by the National Institute on Aging (NIA), part of the National Institutes of Health, and all study data is now freely available to the broader scientific community.